InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients with Chronic Hepatitis C <a href="http://www.hivandhepatitis.com/2008icr/ddw/docs/060608_a.html" target="_blank">http://www.hivandhepatitis.com/2008icr/ddw/docs/060608_a.html</a>